Trial NCT02954653

View at ClinicalTrials.gov 
Org. Study IDs: B7861002

Last trial update was posted on 2019-11-21

MeSH Interventions

Azacitidine Cytarabine Daunorubicin Decitabine

MeSH Conditions

Leukemia Leukemia, Myeloid Leukemia, Myeloid, Acute

Other Conditions

Acute Myeloid Leukemia

Stopping Reasons

The study was terminated due to a change in sponsor prioritization.

Limitations And Caveats

The study was terminated prematurely due to strategic business reasons and was not due to any safety concerns.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID